Emergent BioSolutions Inc. (EBS)
NYSE·Healthcare·Drug Manufacturers - Specialty & Generic
$6.83
-2.78%
Mkt Cap $321.44M
Analyst Ratings
Buy
2
Hold
0
Sell
0
Price Target (3 analysts)
$12.00
Range $12.00 – $12.00
Implied Upside
+75.8%
Consensus $12.00 vs current $6.83